Related references
Note: Only part of the references are listed.Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide
Jing Xue et al.
CELL (2022)
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
Lukas Kraehenbuehl et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
Effects of Brief Adjunctive Metformin Therapy in Virologically Suppressed HIV-Infected Adults on Polyfunctional HIV-Specific CD8 T Cell Responses to PD-L1 Blockade
Glen M. Chew et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2021)
Exacerbated AIDS Progression by PD-1 Blockade during Therapeutic Vaccination in Chronically Simian Immunodeficiency Virus-Infected Rhesus Macaques after Interruption of Antiretroviral Therapy
Chunxiu Wu et al.
JOURNAL OF VIROLOGY (2021)
Impact of Anti-PD-1 and Anti-CTLA-4 on the Human Immunodeficiency Virus (HIV) Reservoir in People Living With HIV With Cancer on Antiretroviral Therapy: The AIDS Malignancy Consortium 095 Study
Thomas A. Rasmussen et al.
CLINICAL INFECTIOUS DISEASES (2021)
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin's lymphoma
Kathryn Lurain et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The impact of immune checkpoint therapy on the latent reservoir in HIV-infected individuals with cancer on antiretroviral therapy
Jillian S. Y. Lau et al.
AIDS (2021)
Suspected Immune-Related Adverse Events With an Anti-PD-1 Inhibitor in Otherwise Healthy People With HIV
Cynthia L. Gay et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
Correlation Between TIGIT Expression on CD8+ T Cells and Higher Cytotoxic Capacity
Jana Blazkova et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Disease Progression in Children With Perinatal Human Immunodeficiency Virus Correlates With Increased PD-1+ CD8 T Cells That Coexpress Multiple Immune Checkpoints
Janki Tailor et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
T cell immune discriminants of HIV reservoir size in a pediatric cohort of perinatally infected individuals
Stefano Rinaldi et al.
PLOS PATHOGENS (2021)
The HIV-1 accessory protein Nef increases surface expression of the checkpoint receptor Tim-3 in infected CD4(+) T cells
Rajesh Abraham Jacob et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Temporal and spatial characterization of negative regulatory T cells in HIV-infected/AIDS patients raises new diagnostic markers and therapeutic strategies
Hui Chen et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Reversal of the CD8+ T-Cell Exhaustion Induced by Chronic HIV-1 Infection Through Combined Blockade of the Adenosine and PD-1 Pathways
Jing Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
PD-1 blockade and vaccination provide therapeutic benefit against SIV by inducing broad and functional CD8+ T cells in lymphoid tissue
Sheikh Abdul Rahman et al.
SCIENCE IMMUNOLOGY (2021)
Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques
Ping Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?
Baptiste Abbar et al.
AIDS (2020)
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality
Giorgia Guaitoli et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Levels of Human Immunodeficiency Virus DNA Are Determined Before ART Initiation and Linked to CD8 T-Cell Activation and Memory Expansion
Genevieve E. Martin et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy
Bernard J. C. Macatangay et al.
AIDS (2020)
Combination therapies currently under investigation in phase I and phase II clinical trials for HIV-1
Hanh Thi Pham et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Combination Immune Checkpoint Blockade to Reverse HIV Latency
Renee M. Van der Sluis et al.
JOURNAL OF IMMUNOLOGY (2020)
HIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells
Jeremie Prevost et al.
JOURNAL OF VIROLOGY (2020)
Immune checkpoint modulation enhances HIV-1 antibody induction
Todd Bradley et al.
NATURE COMMUNICATIONS (2020)
Galectin-9 and VISTA Expression Define Terminally Exhausted T Cells in HIV-1 Infection
Shima Shahbaz et al.
JOURNAL OF IMMUNOLOGY (2020)
Assessment of the Feasibility and Safety of Durvalumab for Treatment of Solid Tumors in Patients With HIV-1 Infection The Phase 2 DURVAST Study
Maria Gonzalez-Cao et al.
JAMA ONCOLOGY (2020)
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
Justin Harper et al.
NATURE MEDICINE (2020)
The Role of Immunomodulatory Receptors in the Pathogenesis of HIV Infection: A Therapeutic Opportunity for HIV Cure?
Hui Chen et al.
FRONTIERS IN IMMUNOLOGY (2020)
CD160 Plays a Protective Role During Chronic Infection by Enhancing Both Functionalities and Proliferative Capacity of CD8+T Cells
Linxia Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumour-intrinsic resistance to immune checkpoint blockade
Anusha Kalbasi et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1+ and TIGIT+ CD4 T Cells
George N. Llewellyn et al.
JOURNAL OF VIROLOGY (2019)
Blockade of the PD-1 axis alone is not sufficient to activate HIV-1 virion production from CD4+ T cells of individuals on suppressive ART
John K. Bui et al.
PLOS ONE (2019)
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individuals
Remi Fromentin et al.
NATURE COMMUNICATIONS (2019)
Single-cell characterization and quantification of translation-competent viral reservoirs in treated and untreated HIV infection
Marion Pardons et al.
PLOS PATHOGENS (2019)
Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage Cancer A Systematic Review
Michael R. Cook et al.
JAMA ONCOLOGY (2019)
Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer
Jacob J. Adashek et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immunotherapy for cancer in people living with HIV: safety with an efficacy signal from the series in real life experience
Jean-Philippe Spano et al.
AIDS (2019)
PD-1 Blockade and TLR7 Activation Lack Therapeutic Benefit in Chronic Simian Immunodeficiency Virus-Infected Macaques on Antiretroviral Therapy
Elena Bekerman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
Between a shock and a hard place: challenges and developments in HIV latency reversal
Jennifer M. Zerbato et al.
CURRENT OPINION IN VIROLOGY (2019)
Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab
Oscar Blanch-Lombarte et al.
JOURNAL OF CLINICAL MEDICINE (2019)
T-cell exhaustion in HIV infection
Craig Fenwick et al.
IMMUNOLOGICAL REVIEWS (2019)
Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir
Timothy N. Hoang et al.
JOURNAL OF VIROLOGY (2019)
Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
Neil J. Shah et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency
Vanessa A. Evans et al.
AIDS (2018)
Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection
E. P. Scully et al.
ANNALS OF ONCOLOGY (2018)
An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients
Elizabeth Colston et al.
PLOS ONE (2018)
Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection
Norma Rallon et al.
PLOS ONE (2018)
Human Immunodeficiency Virus Type-1 Elite Controllers Maintain Low Co-Expression of Inhibitory Receptors on CD4+T Cells
Kajsa Noyan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Immune Protection of SIV Challenge by PD-1 Blockade During Vaccination in Rhesus Monkeys
Enxiang Pan et al.
FRONTIERS IN IMMUNOLOGY (2018)
Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
Zoe Boyer et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
Geetha H. Mylvaganam et al.
JCI INSIGHT (2018)
Immune checkpoint blockade in infectious diseases
Michelle N. Wykes et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer
A. Guihot et al.
ANNALS OF ONCOLOGY (2018)
CTLA-4+PD-1- Memory CD4+ T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques
Colleen S. McGary et al.
IMMUNITY (2017)
Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy
Gabriela Khoury et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy
Cynthia L. Gay et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
HIV-Infected Children Have Elevated Levels of PD-1+ Memory CD4 T Cells With Low Proliferative Capacity and High Inflammatory Cytokine Effector Functions
Julia Foldi et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection
Jeffrey E. Teigler et al.
JOURNAL OF VIROLOGY (2017)
Perturbed CD8+ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals
Johanna Tauriainen et al.
SCIENTIFIC REPORTS (2017)
Durable complete response to nivolumab in a patient with HIV and metastatic non-small cell lung cancer
Brennan McCullar et al.
JOURNAL OF THORACIC DISEASE (2017)
Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade
Katharina Grabmeier-Pfistershammer et al.
CLINICAL IMMUNOLOGY (2017)
Nivolumab in HIV-related non-small-cell lung cancer
M. Hentrich et al.
ANNALS OF ONCOLOGY (2017)
Immune checkpoints and their inhibition in cancer and infectious diseases
Lydia Dyck et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Alemtuzumab induction therapy in HIV-positive renal transplant recipients
Florence E. Mclean et al.
AIDS (2017)
Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab)
Amanda L. Gill et al.
AIDS (2016)
PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
Riddhima Banga et al.
NATURE MEDICINE (2016)
Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change
Giuseppe Pantaleo et al.
CURRENT OPINION IN HIV AND AIDS (2016)
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection
Glen M. Chew et al.
PLOS PATHOGENS (2016)
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Remi Fromentin et al.
PLOS PATHOGENS (2016)
Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection
Matthias Hoffmann et al.
PLOS PATHOGENS (2016)
Acute interstitial nephritis caused by lopinavir/ritonavir in a surgeon receiving antiretroviral postexposure prophylaxis
Mohamed F. Chughlay et al.
AIDS (2015)
Up-regulation of Tim-3 on T cells during acute simian immunodeficiency virus infection and on antigen specific responders
Praveen K. Amancha et al.
AIDS (2015)
Effect of ipilimumab on the HIV reservoir in an HIV-infected individual with metastatic melanoma
Fiona Wightman et al.
AIDS (2015)
Nef promotes evasion of human immunodeficiency virus type 1-infected cells from the CTLA-4-mediated inhibition of T-cell activation
Mohamed El-Far et al.
JOURNAL OF GENERAL VIROLOGY (2015)
The Upregulation of LAG-3 on T Cells Defines a Subpopulation with Functional Exhaustion and Correlates with Disease Progression in HIV-Infected Subjects
Xiaoling Tian et al.
JOURNAL OF IMMUNOLOGY (2015)
Elevated Expression of CD160 and 2B4 Defines a Cytolytic HIV-Specific CD8+ T-Cell Population in Elite Controllers
Carolina Pombo et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Initiation of Antiretroviral Therapy (ART) at Different Stages of HIV-1 Disease Is Not Associated with the Proportion of Exhausted CD8+ T Cells
Sanne Skov Jensen et al.
PLOS ONE (2015)
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst et al.
NATURE COMMUNICATIONS (2015)
Elevation of Tim-3 and PD-1 Expression on T Cells Appears Early in HIV Infection, and Differential Tim-3 and PD-1 Expression Patterns Can Be Induced by Common γ-Chain Cytokines
Zi-Ning Zhang et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Programmed death-1 expression on CD4+ and CD8+ T cells in treated and untreated HIV disease
Leslie R. Cockerham et al.
AIDS (2014)
Expansion of Dysfunctional Tim-3-Expressing Effector Memory CD8+ T Cells during Simian Immunodeficiency Virus Infection in Rhesus Macaques
Tsuyoshi Fujita et al.
JOURNAL OF IMMUNOLOGY (2014)
In Vivo Blockade of the Programmed Cell Death-1 Pathway Using Soluble Recombinant PD-1-Fc Enhances CD4+ and CD8+ T Cell Responses but Has Limited Clinical Benefit
Praveen K. Amancha et al.
JOURNAL OF IMMUNOLOGY (2013)
Immune targeting of PD-1hi expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques
Diego A. Vargas-Inchaustegui et al.
VIROLOGY (2013)
PD-1 and its ligand PD-L1 are progressively up-regulated on CD4 and CD8 T-cells in HIV-2 infection irrespective of the presence of viremia
Rita Tendeiro et al.
AIDS (2012)
Imbalanced Production of Cytokines by T Cells Associates with the Activation/Exhaustion Status of Memory T Cells in Chronic HIV Type 1 Infection
Kaori Nakayama et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2012)
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
Ravi Dyavar Shetty et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Tim-3 Negatively Regulates Cytotoxicity in Exhausted CD8+ T Cells in HIV Infection
Ali Sakhdari et al.
PLOS ONE (2012)
CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction
Yoav Peretz et al.
PLOS PATHOGENS (2012)
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection
Takuya Yamamoto et al.
BLOOD (2011)
Immunogenic and tolerogenic signatures in human immunodeficiency virus (HIV)-infected controllers compared with progressors and a conversion strategy of virus control
T. Whittall et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
B and T Lymphocyte Attenuator Down-regulation by HIV-1 Depends on Type I Interferon and Contributes to T-Cell Hyperactivation
Zheng Zhang et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Regulation of Virus-Specific CD4+ T Cell Function by Multiple Costimulatory Receptors during Chronic HIV Infection
Afework Kassu et al.
JOURNAL OF IMMUNOLOGY (2010)
PD-1 Blockade in Rhesus Macaques: Impact on Chronic Infection and Prophylactic Vaccination
Adam C. Finnefrock et al.
JOURNAL OF IMMUNOLOGY (2009)
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Vijayakumar Velu et al.
NATURE (2009)
Soluble PD-1 rescues the proliferative response of simian immunodeficiency virus-specific CD4 and CD8 T cells during chronic infection
Nattawat Onlamoon et al.
IMMUNOLOGY (2008)
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection
R. Brad Jones et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Human Immunodeficiency Virus Type 1 Nef Induces Programmed Death 1 Expression through a p38 Mitogen-Activated Protein Kinase-Dependent Mechanism
Karuppiah Muthumani et al.
JOURNAL OF VIROLOGY (2008)
Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
Daniel E. Kaufmann et al.
NATURE IMMUNOLOGY (2007)
SIV-specific CD8+ T cells express high levels of PD1 and cytokines but have impaired proliferative capacity in acute and chronic SIVmac251 infection
Constantinos Petrovas et al.
BLOOD (2007)
PD-1 up-regulation is correlated with HIV-specific memory CD8(+) T-cell exhaustion in typical progressors, but not in long-terrn nonprogressors
Ji-Yuan Zhang et al.
BLOOD (2007)
CTLA-4 blockade decreases TGF-β, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques
Anna Hryniewicz et al.
BLOOD (2006)
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Constantinos Petrovas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Lydie Trautmann et al.
NATURE MEDICINE (2006)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention
QB Leng et al.
AIDS (2002)
Share Paper
